Ryman Healthcare Limited
RHCGF
$1.44
$0.22518.60%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -3.88% | 4.53% | |||
| Total Other Revenue | -3.88% | -0.41% | |||
| Total Revenue | -3.88% | 4.23% | |||
| Cost of Revenue | -3.88% | 15.66% | |||
| Gross Profit | 3.88% | -163.20% | |||
| SG&A Expenses | -- | -- | |||
| Depreciation & Amortization | -3.88% | -12.32% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.88% | 13.73% | |||
| Operating Income | 3.88% | -1,699.22% | |||
| Income Before Tax | 3.88% | -315.61% | |||
| Income Tax Expenses | -3.88% | 69.32% | |||
| Earnings from Continuing Operations | 3.88% | -643.75% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.88% | -643.75% | |||
| EBIT | 3.88% | -1,699.22% | |||
| EBITDA | 3.88% | -220.12% | |||
| EPS Basic | 3.88% | -609.76% | |||
| Normalized Basic EPS | 3.80% | -102.20% | |||
| EPS Diluted | 3.88% | -614.66% | |||
| Normalized Diluted EPS | 3.80% | -102.20% | |||
| Average Basic Shares Outstanding | 0.00% | 6.56% | |||
| Average Diluted Shares Outstanding | 0.00% | 6.56% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||